Avience Biomedicals Ltd.
AVIENCE
Avience Biomedicals Ltd.
AVIENCE
Avience Biomedicals Ltd. Share Price
266.90 -10.10 (-3.65%)Share Price Today – Avience Biomedicals Ltd.
As of October 16, 2026, Avience Biomedicals Ltd. share price is ₹266.90. The stock opened at ₹270.50 and closed at ₹277.00 in the previous session. During the trading session, the share price moved between ₹263.15 and ₹274.00. Over the last 52 weeks, the stock has recorded a low of ₹222.00 and a high of ₹414.95. In terms of performance, the stock has delivered 30.1% returns over the past six months and 30.1% returns over the last year.
Fundamentals
Market Cap₹148Cr | EPS₹21.71 |
P/E Ratio (TTM)12.76 | Industry P/E (TTM)31.50 |
P/B Ratio3.55 | Long Term D/E0.92 |
ROE32.37% | Dividend Yield (TTM)0.00% |
FAQs on Avience Biomedicals Ltd.
The share price of Avience Biomedicals Ltd. is ₹266.90 on NSE as of 16/10/2026, 9:27:35 pm. Share prices may change frequently due to market movements.
The market capitalisation of Avience Biomedicals Ltd. is ₹148Cr as of 16/10/2026, 9:27:35 pm
The current Price to Earnings (P/E) ratio of Avience Biomedicals Ltd. is 12.76 as of 16/10/2026, 9:27:35 pm
The Price to Book (P/B) ratio of Avience Biomedicals Ltd. stands at 3.55 as of 16/10/2026, 9:27:35 pm
Avience Biomedicals Ltd. reported an ROE of 32.37% for the last reported financial year on a consolidated account basis.
As of 16/10/2026, 9:27:35 pm, Avience Biomedicals Ltd.’s shareholding pattern is: promoters hold undefined%, FIIs hold undefined%, DIIs hold undefined%, and public shareholders hold undefined%.
The 52-week high of Avience Biomedicals Ltd. is ₹414.95 and the 52-week low is ₹222.00 as of 16/10/2026, 9:27:35 pm.
The earnings per share (EPS) of Avience Biomedicals Ltd. is -- for the quarter ended Sep 2026.
The stock symbol of Avience Biomedicals Ltd. is AVIENCE.
You can buy Avience Biomedicals Ltd. shares by opening a demat and trading account with PhonePe Invest and placing a buy order on NSE or BSE during market hours.
The fair value of Avience Biomedicals Ltd. depends on factors such as earnings growth, financial performance, and overall market conditions. Investors should assess fundamentals before making investment decisions.
Earnings Per Share
Earnings per share (EPS) measures the profit earned by a company for each of its outstanding shares. Generally, the higher a company’s EPS is, the more profitable it is considered to be.
Income Statement
Also called a profit and loss statement, an income statement shows a company’s income, expenses, and how much profit or loss it has made over a specific accounting period. It provides a clear view of how well the business is running.
| Particulars (in Cr) | Mar 2026 | Y/Y Change |
|---|---|---|
| Operating Revenue | 52.51 | +16.07% |
| Other Income | 0.29 | -60.27% |
| Total Income | 52.80 | +14.86% |
| Total Expenditure | 40.33 | +11.50% |
| EBIDT | 15.23 | +25.45% |
| Depreciation | 1.22 | +41.86% |
| Interest | 1.54 | +4.05% |
| Tax | 3.71 | +44.36% |
| Net Profit | 8.75 | +21.02% |
Balance Sheet
A balance sheet is a financial statement that details a company’s assets, liabilities, and shareholders’ equity at a given time. It helps assess how financially strong and stable the company is.
| Particulars (in Cr) | Mar 2026 |
|---|---|
| Total Current Assets | 46.54 |
| Total Non-Current Assets | 31.40 |
| Fixed assets | 28.91 |
| Total Assets | 77.94 |
| Total Current liabilities | 32.96 |
| Total Non Current Liabilities | 13.57 |
| Total Equity Plus Liabilities | 77.94 |
| Total Shareholder Funds | 31.41 |
| Total Debt to Equity | 92.00% |
Cash Flow
Cash flow highlights the cash or cash equivalents moving in and out of a company during a particular period. It provides a clear picture of how well a company manages its cash by tracking its operating, investing and financing activities.
| Particulars (in Cr) | Mar 2026 |
|---|---|
| Cash from Operating Activity | 5.91 |
| Cash from Financing Activities | 5.42 |
| Cash from Investing Activities | -13.27 |
| Net Cash Flow | -1.95 |
Time Period: Daily
SMA/EMA (Moving Average) Analysis
Bullish Moving Averages0
Bearish Moving Averages11
5 Day
277.1010 Day
285.8020 Day
317.0030 Day
316.0050 Day
291.60Indicators
RSI (14)
40.84MACD (12, 26)
-9.19MACD Signal Line (9)
-1.08MFI (14)
36.65ATR (14)
21.34ADX (14)
25.48ROC (21)
-20.77ROC (125)
--Pivot Analysis
Pivot analysis uses a special price point, called the pivot point, to show the overall market trend during different periods. This pivot point is the average of the previous day’s high, low, and closing prices of a specific asset.
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Note: Support and Resistance level for the day, calculated based on price range of the previous trading day.
Volume Analysis
Volume analysis tracks how many shares were traded for a specific period. Total traded volume represents the overall number of shares traded, while combined delivery volume indicates only those shares which are delivered (transferred for ownership). Delivered shares indicate long-term investor interest.
Avience Biomedicals Ltd.
AVIENCE
Open Price | 270.50 |
Previous Close | 277.00 |
Volume | 33,000 |
Average Price | 266.34 |
Upper Circuit | 290.85 |
Lower Circuit | 263.15 |
Historical Performance
| NA | 1 Day |
| NA | 5 Days |
| NA | 1 Month |
| NA | 3 Months |
| NA | 1 Year |
| NA | 5 Years |
| NA | 10 Years |